Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00328445 · ClinicalTrials.gov registry record · NA

Randomized Trial of the Positive Action Program in Hawaii Schools

A NA study of Substance Use and Violence, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
NA
Development phase
2,500
Enrollment target
3
Study locations

NCT00328445: Completed NA study of Substance Use and Violence, sponsored by National Institute on Drug Abuse (NIDA).

NCT00328445 is a NA study of Substance Use and Violence that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 2,500 participants, above the 1,232-participant average among 88 other Substance Use trials with a reported enrollment target (103% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00328445, a NA study of Substance Use and Violence, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
NA
Development phase
2,500 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to determine the effectiveness of the Positive Action program on reducing negative behaviors, increasing positive behaviors and improving academic achievement of elementary school students.

Interventions

  • BEHAVIORAL Positive Action

Study Locations (3)

Idaho

  • Positive Action, Inc. - Twin Falls

Illinois

  • University of Illinois at Chicago - Chicago

Oregon

  • Oregon State University - Corvallis

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2001-04
Est. Completion 2006-06
Phase NA

What the finished NCT00328445 record still lists

NCT00328445 is an interventional study that assigns participants to a tested intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,232-participant average among 88 other Substance Use trials with a reported enrollment target (103% higher).

The record links to 5 conditions, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which Positive Action is the first listed.

NCT00328445 reports a single indexed study location in Idaho, Illinois, Oregon.

Frequently Asked Questions

What is clinical trial NCT00328445 about?

NCT00328445 is a clinical study titled "Randomized Trial of the Positive Action Program in Hawaii Schools". The purpose of this study is to determine the effectiveness of the Positive Action program on reducing negative behaviors, increasing positive behaviors and improving academic achievement of elementary school students.

What is the current status of trial NCT00328445?

This trial is currently completed. It is a NA study. The enrollment target is 2,500 participants. The study started on 2001-04. Estimated completion is 2006-06.

What conditions does trial NCT00328445 study?

This clinical trial studies the following conditions: Substance Use, Violence, Prosocial Behavior, Academic Achievement, Character.

What interventions are being tested in trial NCT00328445?

The interventions under investigation include: Positive Action (BEHAVIORAL).

Who is sponsoring clinical trial NCT00328445?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00328445 being conducted?

This trial has 3 study locations across Idaho, Illinois, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00328445's enrollment target sits among peer trials

2,500 3rd of 88 higher than 86 of 88 other Substance Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001160 · 2,500 participants

    Studies on Tumors of the Thyroid

  • NCT01904188 · 2,500 participants

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

  • NCT02257229 · 2,500 participants

    Prospective Evaluation of Treatment for Clubfoot

  • NCT02530658 · 2,500 participants

    Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00328445, the US trial registry maintained by the National Library of Medicine. NCT00328445 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.